| 发明名称 |
ANTIVIRAL COMPOUNDS |
| 摘要 |
The invention provides a pharmaceutical composition comprising: (1) a compound of the formula:
or a pharmaceutically acceptable salt thereof; (2) a NS5B polymerase inhibitor; and (3) a NS3 protease inhibitor; and relates to the use of (1), (2) and (3), in combination, in the prophylactic or therapeutic treatment of hepatitis C or a hepatitis C associated disorder. |
| 申请公布号 |
KR20140014393(A) |
申请公布日期 |
2014.02.06 |
| 申请号 |
KR20117029699 |
申请日期 |
2010.05.12 |
| 申请人 |
GILEAD SCIENCES, INC. |
发明人 |
GUO HONGYAN;KATO DARRYL;KIRSCHBERG THORSTEN A.;LIU HONGTAO;LINK JOHN O.;MITCHELL MICHAEL L.;PARRISH JAY P.;SQUIRES NEIL;SUN JIANYU;TAYLOR JAMES;BACON ELIZABETH M.;CANALES EDA;CHO AESOP;KIM CHOUNG U.;COTTELL JEROMY J.;DESAI MANOJ C.;HALCOMB RANDALL L.;KRYGOWSKI EVAN S.;LAZERWITH SCOTT E.;LIU QI;MACKMAN RICHARD;PYUN, HYUNG JUNG;SAUGIER JOSEPH H.;TRENKLE JAMES D.;TSE WINSTON C.;VIVIAN RANDALL W.;SCHROEDER SCOTT D.;WATKINS WILLIAM J.;XU LIANHONG;YANG ZHENG YU;KELLAR TERRY;SHENG XIAONING;CLARKE MICHAEL O'NEIL HANRAHAN;CHOU CHIEN HUNG;GRAUPE MICHAEL;JIN HAOLUN;MCFADDEN RYAN;MISH MICHAEL R.;METOBO SAMUEL E.;PHILLIPS BARTON W.;VENKATARAMANI CHANDRASEKAR |
| 分类号 |
C07D403/14;A61K31/4178;A61P31/00;C07D403/12 |
主分类号 |
C07D403/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
